Viewing Study NCT06773195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2026-01-27 @ 3:06 AM
Study NCT ID: NCT06773195
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-01-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelofibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None post-ET myelofibrosis View
None post-PV myelofibrosis, View
None post-pre-fibrotic myelofibrosis View
None JAK/MEK inhibition View
None Ruxolitinib View
None Ulixertinib View